363 related articles for article (PubMed ID: 32033229)
21. Response of arsenic-induced oxidative stress, DNA damage, and metal imbalance to combined administration of DMSA and monoisoamyl-DMSA during chronic arsenic poisoning in rats.
Bhadauria S; Flora SJ
Cell Biol Toxicol; 2007 Mar; 23(2):91-104. PubMed ID: 17086449
[TBL] [Abstract][Full Text] [Related]
22. Arsenic and lead induced free radical generation and their reversibility following chelation.
Flora SJ; Flora G; Saxena G; Mishra M
Cell Mol Biol (Noisy-le-grand); 2007 Apr; 53(1):26-47. PubMed ID: 17519110
[TBL] [Abstract][Full Text] [Related]
23. DMSA and DMPS--water soluble antidotes for heavy metal poisoning.
Aposhian HV
Annu Rev Pharmacol Toxicol; 1983; 23():193-215. PubMed ID: 6307120
[No Abstract] [Full Text] [Related]
24. Efficacy of dimercapto chelating agents for the treatment of poisoning by percutaneously applied dichloro(2-chlorovinyl)arsine in rabbits.
Inns RH; Rice P
Hum Exp Toxicol; 1993 May; 12(3):241-6. PubMed ID: 8100435
[TBL] [Abstract][Full Text] [Related]
25. Comparative efficacy of Nano and Bulk Monoisoamyl DMSA against arsenic-induced neurotoxicity in rats.
Naqvi S; Kumar P; Flora SJS
Biomed Pharmacother; 2020 Dec; 132():110871. PubMed ID: 33069968
[TBL] [Abstract][Full Text] [Related]
26. Strategies for safe and effective therapeutic measures for chronic arsenic and lead poisoning.
Kalia K; Flora SJ
J Occup Health; 2005 Jan; 47(1):1-21. PubMed ID: 15703449
[TBL] [Abstract][Full Text] [Related]
27. Topical efficacy of dimercapto-chelating agents against lewisite-induced skin lesions in SKH-1 hairless mice.
Mouret S; Wartelle J; Emorine S; Bertoni M; Nguon N; Cléry-Barraud C; Dorandeu F; Boudry I
Toxicol Appl Pharmacol; 2013 Oct; 272(2):291-8. PubMed ID: 23806213
[TBL] [Abstract][Full Text] [Related]
28. Inadvertent poisoning of seven teenagers with monosodium methanearsonate.
Cox RD; Orledge J
Clin Toxicol (Phila); 2011 Mar; 49(3):167-70. PubMed ID: 21495885
[TBL] [Abstract][Full Text] [Related]
29. Effect of oral treatment with Bal, DMPS or DMSA arsenic in organs of mice injected with arsenic trioxide.
Schäfer B; Kreppel H; Reichl FX; Fichtl B; Forth W
Arch Toxicol Suppl; 1991; 14():228-30. PubMed ID: 1666826
[No Abstract] [Full Text] [Related]
30. Therapeutic potential of monoisoamyl and monomethyl esters of meso 2,3-dimercaptosuccinic acid in gallium arsenide intoxicated rats.
Flora SJ; Mehta A; Rao PV; Kannan GM; Bhaskar AS; Dube SN; Pant BP
Toxicology; 2004 Feb; 195(2-3):127-46. PubMed ID: 14751669
[TBL] [Abstract][Full Text] [Related]
31. Effect of dithiol chelating agents on [3H]MK-801 and [3H]glutamate binding to synaptic plasma membranes.
Nogueira CW; Rocha JB; Souza DO
Neurochem Res; 2001 Dec; 26(12):1305-10. PubMed ID: 11885782
[TBL] [Abstract][Full Text] [Related]
32. Combined administration of taurine and monoisoamyl DMSA protects arsenic induced oxidative injury in rats.
Flora SJ; Chouhan S; Kannan GM; Mittal M; Swarnkar H
Oxid Med Cell Longev; 2008; 1(1):39-45. PubMed ID: 19794907
[TBL] [Abstract][Full Text] [Related]
33. DMPS-arsenic challenge test. II. Modulation of arsenic species, including monomethylarsonous acid (MMA(III)), excreted in human urine.
Aposhian HV; Zheng B; Aposhian MM; Le XC; Cebrian ME; Cullen W; Zakharyan RA; Ma M; Dart RC; Cheng Z; Andrewes P; Yip L; O'Malley GF; Maiorino RM; Van Voorhies W; Healy SM; Titcomb A
Toxicol Appl Pharmacol; 2000 May; 165(1):74-83. PubMed ID: 10814555
[TBL] [Abstract][Full Text] [Related]
34. Chelation in metal intoxication--Principles and paradigms.
Aaseth J; Skaug MA; Cao Y; Andersen O
J Trace Elem Med Biol; 2015; 31():260-6. PubMed ID: 25457281
[TBL] [Abstract][Full Text] [Related]
35. Relationships between the renal handling of DMPS and DMSA and the renal handling of mercury.
Zalups RK; Bridges CC
Chem Res Toxicol; 2012 Sep; 25(9):1825-38. PubMed ID: 22667351
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic potential of meso 2,3-dimercaptosuccinic acid or 2,3-dimercaptopropane 1-sulfonate in chronic arsenic intoxication in rats.
Flora SJ; Dube SN; Arora U; Kannan GM; Shukla MK; Malhotra PR
Biometals; 1995 Apr; 8(2):111-6. PubMed ID: 7734923
[TBL] [Abstract][Full Text] [Related]
37. Survival without peripheral neuropathy after massive acute arsenic poisoning: Treated by 2,3-dimercaptopropane-1-sulphonate.
Lu PH; Tseng JC; Chen CK; Chen CH
J Clin Pharm Ther; 2017 Aug; 42(4):506-508. PubMed ID: 28547870
[TBL] [Abstract][Full Text] [Related]
38. Amelioration by BAL (2,3-dimercapto-1-propanol) and DMPS (sodium 2,3-dimercapto-1-propanesulfonic acid) of arsenite developmental toxicity in mice.
Domingo JL; Bosque MA; Llobet JM; Corbella J
Ecotoxicol Environ Saf; 1992 Jun; 23(3):274-81. PubMed ID: 1376232
[TBL] [Abstract][Full Text] [Related]
39. Reversal of oxophenylarsine-induced inhibition of glucose uptake in MDCK cells.
Liebl B; Mückter H; Doklea E; Fichtl B; Forth W
Fundam Appl Toxicol; 1995 Aug; 27(1):1-8. PubMed ID: 7589919
[TBL] [Abstract][Full Text] [Related]
40. Arsenic and copper excretion after treatment of arsenic poisoning in rats with heavy-metal antagonists.
Maehashi H; Yamaguchi Y; Tsutsumi S
Dev Toxicol Environ Sci; 1983; 11():325-8. PubMed ID: 6329629
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
